Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer

Histopathology

Volumn 65, Issue 2, 2014, Pages 155-163

  Al Sohaily, Sam ^a,b,c   Henderson, Christopher ^c,d   Selinger, Christina ^e   Pangon, Laurent ^a   Segelov, Eva ^f   Kohonen Corish, Maija R J ^a,f,g   Warusavitarne, Janindra ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Campbelltown and Fairfield Hospitals   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d LIVERPOOL HOSPITAL   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Chemotherapy; Colorectal cancer; Prognosis; SATB1; Survival

Indexed keywords

AT RICH SEQUENCE BINDING PROTEIN 1; BETA CATENIN; MATRIX ATTACHMENT REGION BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; SATB1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; BIOSYNTHESIS; CARCINOMA; COLORECTAL TUMOR; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904288169     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12295     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55; 74-108.
2. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 2009; 18; 1688-1694.
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010; 60; 277-300.
4. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T. A tissue-specific mar/sar DNA-binding protein with unusual binding site recognition. Cell 1992; 70; 631-645.
5. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T. SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 2002; 419; 641-645.
6. Han H-J, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452; 187-193.
7. Iorns E, Hnatyszyn HJ, Seo P, Clarke J, Ward T, Lippman M. The role of SATB1 in breast cancer pathogenesis. J. Natl Cancer Inst. 2010; 102; 1284-1296.
8. Cheng C, Lu X, Wang G et al. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS 2010; 118; 855-863.
9. Lu X, Cheng C, Zhu S et al. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol. Rep. 2010; 24; 981-987.
10. Zhao X-D, Ji W-y, Zhang W et al. Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J. Otorhinolaryngol. Relat. Spec. 2010; 72; 1-5.
11. Selinger CIP, Cooper WAMP, Al-Sohaily SM et al. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J. Thorac. Oncol. 2011; 6; 1179-1189.
12. Behrens J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans. 2005; 33; 672-675.
13. Notani D, Gottimukkala KP, Jayani RS et al. Global regulator SATB1 recruits beta-catenin and regulates T(h)2 differentiation in Wnt-dependent manner. PLoS Biol. 2010; 8; e1000296.
14. Wang S, Zhou J, Wang X-Y et al. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J. Pathol. 2009; 219; 114-122.
15. Ahlfors H, Limaye A, Elo LL et al. SATB1 dictates expression of multiple genes including Il-5 involved in human T helper cell differentiation. Blood 2010; 116; 1443-1453.
16. Consorti F, Lorenzotti A, Midiri G, Di Paola M. Prognostic significance of mucinous carcinoma of colon and rectum: a prospective case-control study. J. Surg. Oncol. 2000; 73; 70-74.
17. Min BS, Kim NK, Ko YT et al. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study. Hepatogastroenterology 2009; 56; 984-988.
18. Meng WJ, Yan H, Zhou B et al. Correlation of SATB1 overexpression with the progression of human rectal cancer. Int. J. Colorectal Dis. 2012; 27; 143-150.
19. Fang XF, Hou ZB, Dai XZ et al. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World J. Gastroenterol. 2013; 19; 2331-2339.
20. Zhang J, Zhang B, Zhang X et al. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS ONE 2013; 8; e47902.
21. Nodin B, Johannesson H, Wangefjord S et al. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn. Pathol. 2012; 7; 115.
22. Gill S, Loprinzi CL, Sargent DJ et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J. Clin. Oncol. 2004; 22; 1797-1806.